BioCentury
ARTICLE | Finance

Lean machine for ADCs

SynAffix investors want ADC company to focus on platform tech, not products

February 24, 2014 8:00 AM UTC

Platform companies are notorious for the heavy cash required to turn their platforms into products, but SynAffix B.V. investors are taking a different tack. The syndicate in last week's series A round is hoping for a big return by keeping the company financially lean.

The plan is to focus on optimizing the biotech's ADC technology rather than putting a lot of cash into products...